Suehara, Yasuhito
Sakamoto, Kana
Fujisawa, Manabu https://orcid.org/0009-0007-1122-6549
Fukumoto, Kota
Abe, Yoshiaki https://orcid.org/0000-0002-1021-7911
Makishima, Kenichi https://orcid.org/0000-0002-5808-816X
Suma, Sakurako
Sakamoto, Tatsuhiro https://orcid.org/0000-0001-6852-0721
Hattori, Keiichiro
Sugio, Takeshi
Kato, Koji
Akashi, Koichi https://orcid.org/0000-0001-7763-5723
Matsue, Kosei
Narita, Kentaro
Takeuchi, Kengo
Carreras, Joaquim https://orcid.org/0000-0002-6129-8299
Nakamura, Naoya
Chiba, Kenichi
Shiraishi, Yuichi
Miyano, Satoru https://orcid.org/0000-0002-1753-6616
Ogawa, Seishi
Chiba, Shigeru
Sakata-Yanagimoto, Mamiko https://orcid.org/0000-0001-7310-8045
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21H02945, JP19K23879, JP21K16262, JP20J20851, JP23K15293, JP23K15317, JP21K16261, JP23K15316)
Japan Agency for Medical Research and Development (JP22ck0106544, JP23ck0106797, JP23tk0124002, JP24ck0106908)
MEXT | Japan Science and Technology Agency (JP22zf0127009)
Kobayashi Foundation for Cancer Research, Kobayashi Foundation, Chemo-Sero Therapeutic Research Institute, Takeda Science Foundation, and Uehara Memorial Foundation
Gilead Sciences
Leukemia and Lymphoma Society (3442-25)
Article History
Received: 21 September 2024
Revised: 12 February 2025
Accepted: 7 March 2025
First Online: 31 March 2025
Competing interests
: The authors declare no competing interests.